GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the SARS-cov-2 receptor binding domain in complex with vnar 2C02

Analyse Crystal structure of the SARS-cov-2 receptor binding domain in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7SPP
Type
protein
Length
305 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike protein S1; Vnar 2C02
UniProt
P0DTC2
Ligands
NAG, CL
Pockets
3 · best druggability 0.47

Structure

x-ray diffraction · 2 distinct chains · 14% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASpike protein S1protein19518% helix, 30% strandP0DTC2
CVnar 2C02protein1105% helix, 58% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains A
  • CL · Chloride ion · ion · chains C
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1650.470.8315empty
21100.430.7720empty
3600.380.7915empty

Interfaces

1 interface between chains.

  • A–C · 866 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 7SPP · Crystal structure of the SARS-CoV-2 receptor binding domain in complex with VNAR 2C02 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.